TickerFacts.

Cartesian Therapeutics, Inc. (RNAC): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-30, first reflected in a filing dated 2024-05-08. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

25.97M
Year ended 2025-12-31
145.87M2019-12-31: 45.55M2020-12-31: 101.20M2021-12-31: 114.33M2022-12-31: 145.87M2023-12-31: 5.17M2024-12-31: 17.36M2025-12-31: 25.97M25.97M
2019-12-31 Weighted Average Diluted Shares (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3125.97M+49.6%2026-03-09, From 2025-01-01
2024-12-3117.36M+235.7%2026-03-09, From 2024-01-01
2023-12-315.17Mn/c2025-03-13, From 2023-01-01
2022-12-31145.87M+27.6%2024-03-07, From 2022-01-01
2021-12-31114.33M+13.0%2024-03-07, From 2021-01-01
2020-12-31101.20M+122.2%2023-03-02, From 2020-01-01
2019-12-3145.55Mn/a2022-03-10, From 2019-01-01